In response to the worldwide outbreak of COVID-19, Asuragen developed a number of Armored RNA controls to safely test for the presence of the novel coronavirus as an alternative to working with live virus.  Although Armored controls have been used in IVD assays for more than 20 years, the technology this year has quickly been adopted worldwide to allow companies to rapidly pivot focus.  Here we highlight case studies where Armored Controls are being used to not only assist in pandemic research efforts, but push the limits of quantitative diagnostic testing.

Please fill out the information below to access the video.

Back To

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.